Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from GENinCode UK Ltd. ( (GB:GENI) ) is now available.
GENinCode PLC has announced a conditional retail offer of new ordinary shares through RetailBook, priced at 3.7 pence per share, reflecting a discount of 5.13% from the previous day’s closing price. The offer is part of broader fundraising efforts, alongside a placing to institutional investors, to support regulatory and commercial activities, primarily in the US, and to drive the company towards profitability. The retail offer aims to engage both existing shareholders and new investors, with a minimum subscription requirement of £50 and a maximum allocation of £500,000. The proceeds will aid in the completion of US regulatory programs and further commercial expansion.
More about GENinCode UK Ltd.
GENinCode PLC is a genetics company focused on the prevention of cardiovascular disease and the early detection of ovarian cancer. The company operates in the biotechnology industry, with a market focus on expanding its activities in the UK, Europe, and the US, aiming for regulatory and commercial advancements.
YTD Price Performance: 2.63%
Average Trading Volume: 592,410
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £6.9M
For detailed information about GENI stock, go to TipRanks’ Stock Analysis page.
